A package of Molacovir produced in Laos (Photo: Laotiantimes.com) Vientiane (VNA) – Laos is to step up production of its Laos is to step up production of its antiviral drug molnupiravir with the trade name of Molacovir to serve treatment of COVID-19 patients with mild symptoms. 3 – the medicine manufacturer in Laos, said demand for the medication is to triple this year, Vientiane Times reports. The factory, which began producing the drug in December last year, has been unable to meet demand because of the increase in the number of COVID-19 patients. The factory is selling Molacovir at 400,000 LAK (36 USD) for one course of treatment, which lasts for five days. To qualify for treatment, patients must not show signs of pneumonia or oxygen shortage.

Source: Viet Nam News January 13, 2022 20:37 UTC